» Articles » PMID: 28683206

Changes in Mitochondrial Properties May Contribute to Enhanced Resistance to Ischemia-reperfusion Injury in the Diabetic Rat Heart

Overview
Specialties Pharmacology
Physiology
Date 2017 Jul 7
PMID 28683206
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes mellitus, besides having deleterious effects, induces cardiac adaptation that may reduce the heart's susceptibility to ischemia-reperfusion (IR) injury. This study aimed to investigate whether changes in mitochondrial properties are involved in the mechanisms of increased resistance of the diabetic heart to IR. Adult male Wistar rats were made diabetic by a single dose of streptozotocin (65 mg·kg, i.p.), and on the day 8, Langendorff-perfused hearts were subjected to 30 min global ischemia and 40 min reperfusion. Baseline preischemic parameters in the diabetic hearts did not differ markedly from those in the nondiabetic controls, except for lower left ventricular developed pressure, higher mitochondrial membrane fluidity, and protein levels of manganese superoxide dismutase. On the other hand, diabetic hearts showed significantly better post-IR functional restoration and reduced arrhythmogenesis associated with lower reactive oxygen species production as compared with healthy controls. IR decreased membrane fluidity in both experimental groups; however, it led to a complete recovery of mitochondrial Mg-ATPase activity in diabetics in contrast to its reduction in nondiabetics. These findings indicate that the heart may become adapted to diabetes-induced alterations that might increase its tolerance to an ischemic insult. Preserved mitochondrial function might play a role in the mechanisms of the heart's resistance to IR injury in diabetics.

Citing Articles

Mitochondrial Peroxiredoxins and Monoamine Oxidase-A: Dynamic Regulators of ROS Signaling in Cardioprotection.

Ferko M, Alanova P, Janko D, Opletalova B, Andelova N Physiol Res. 2025; 73(6):887-900.

PMID: 39903882 PMC: 11835206.


Dichloroacetate as a metabolic modulator of heart mitochondrial proteome under conditions of reduced oxygen utilization.

Andelova N, Waczulikova I, Kunstek L, Talian I, Ravingerova T, Jasova M Sci Rep. 2022; 12(1):16348.

PMID: 36175475 PMC: 9522880. DOI: 10.1038/s41598-022-20696-5.


Risk Factors of Ischemia Reperfusion Injury After PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction and its Influence on Prognosis.

Zhang L, Wang L, Tao L, Chen C, Ren S, Zhang Y Front Surg. 2022; 9:891047.

PMID: 35747437 PMC: 9209655. DOI: 10.3389/fsurg.2022.891047.


Pemafibrate suppresses oxidative stress and apoptosis under cardiomyocyte ischemia-reperfusion injury in type 1 diabetes mellitus.

Li W, Xu J, Guo X, Xia X, Sun Y Exp Ther Med. 2021; 21(4):331.

PMID: 33732304 PMC: 7903427. DOI: 10.3892/etm.2021.9762.


The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.

Ravingerova T, Kindernay L, Bartekova M, Ferko M, Adameova A, Zohdi V Int J Mol Sci. 2020; 21(21).

PMID: 33114290 PMC: 7660609. DOI: 10.3390/ijms21217889.